UBS Global Research on Tuesday raised its year-end target for the benchmark S&P 500 index to 5,850 points from an earlier ...

The S&P 500’s information-technology sector was dropping sharply heading toward the closing bell on Tuesday, dragging down ...

Short interest for healthcare stocks in S&P 500 increased during September end vs. last month, with Moderna being most ...

AbbVie has been reporting an earnings decline because its former lead drug, Humira, lost patent-protected market exclusivity ...

The S&P 500 advanced 0.8% on Monday, adding to the benchmark index's all-time high Friday for a second straight record close.

Shares of Oracle and Sea Limited are up 68% and 158%, respectively, so far in 2024, and they are positioned for another ...

The S&P 500 finished the week ending October 11 with another record-breaking rally, up 0.97% from last Friday.

The Dow and S&P 500 notched new highs on Friday, with the broader index closing above 5,800 for the first time as big US ...

The S&P 500 set its 44th record closing high of the year yesterday, marking a significant milestone in 2024's stock market ...

Patient investors can enjoy receiving dividends while waiting for top-line growth to accelerate. In a positive sign, the ...

The broad index gained 0.6% to end at 5,815.03, while the Dow rallied 409.74 points, or nearly 1%, to finish at 42,863.86.

With 80 consecutive years of dividend payments under its belt and 56 consecutive years of dividend increases, it's undeniable ...